EGFR and lung cancer: The secondary T790M mutation within the ATP site of EGFR is the most common mechanism of resistance to the first generation EGFR-TKIs in lung cancers 38, which reduces the binding efficacy of EGFR-TKIs to EGFR kinase domain 39.